nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Ocular hyperaemia—Gefitinib—lung cancer	0.0412	0.0649	CcSEcCtD
Naphazoline—Keratitis—Gefitinib—lung cancer	0.0298	0.0469	CcSEcCtD
Naphazoline—Lacrimation increased—Pemetrexed—lung cancer	0.0211	0.0332	CcSEcCtD
Naphazoline—Ocular discomfort—Methotrexate—lung cancer	0.0181	0.0285	CcSEcCtD
Naphazoline—Keratitis—Erlotinib—lung cancer	0.0178	0.028	CcSEcCtD
Naphazoline—Eye pain—Gefitinib—lung cancer	0.0155	0.0245	CcSEcCtD
Naphazoline—Lacrimation—Irinotecan—lung cancer	0.014	0.0221	CcSEcCtD
Naphazoline—NISCH—Podofilox—Teniposide—lung cancer	0.0134	0.239	CbGdCrCtD
Naphazoline—NISCH—Paclitaxel—Docetaxel—lung cancer	0.0124	0.222	CbGdCrCtD
Naphazoline—Keratitis—Paclitaxel—lung cancer	0.0104	0.0163	CcSEcCtD
Naphazoline—Eye disorder—Crizotinib—lung cancer	0.00999	0.0157	CcSEcCtD
Naphazoline—Redness—Paclitaxel—lung cancer	0.00995	0.0157	CcSEcCtD
Naphazoline—NISCH—mammary gland—lung cancer	0.00989	0.199	CbGeAlD
Naphazoline—Lacrimation—Docetaxel—lung cancer	0.00968	0.0152	CcSEcCtD
Naphazoline—Eye disorder—Pemetrexed—lung cancer	0.00913	0.0144	CcSEcCtD
Naphazoline—Eye disorder—Gefitinib—lung cancer	0.00907	0.0143	CcSEcCtD
Naphazoline—Lacrimation increased—Irinotecan—lung cancer	0.00894	0.0141	CcSEcCtD
Naphazoline—Vision blurred—Crizotinib—lung cancer	0.00877	0.0138	CcSEcCtD
Naphazoline—NISCH—Vincristine—Vinorelbine—lung cancer	0.00854	0.152	CbGdCrCtD
Naphazoline—Erythema—Pemetrexed—lung cancer	0.0085	0.0134	CcSEcCtD
Naphazoline—Sweating—Teniposide—lung cancer	0.00845	0.0133	CcSEcCtD
Naphazoline—Redness—Docetaxel—lung cancer	0.00843	0.0133	CcSEcCtD
Naphazoline—NISCH—Podofilox—Etoposide—lung cancer	0.00798	0.142	CbGdCrCtD
Naphazoline—Hypertension—Pemetrexed—lung cancer	0.00734	0.0116	CcSEcCtD
Naphazoline—Lacrimation increased—Paclitaxel—lung cancer	0.00729	0.0115	CcSEcCtD
Naphazoline—NISCH—Vinblastine—Vinorelbine—lung cancer	0.00687	0.123	CbGdCrCtD
Naphazoline—NISCH—Vincristine—Vinblastine—lung cancer	0.00683	0.122	CbGdCrCtD
Naphazoline—Sweating—Topotecan—lung cancer	0.00626	0.00986	CcSEcCtD
Naphazoline—Lacrimation increased—Docetaxel—lung cancer	0.00618	0.00973	CcSEcCtD
Naphazoline—Lacrimation—Doxorubicin—lung cancer	0.00604	0.00951	CcSEcCtD
Naphazoline—Hypertension—Teniposide—lung cancer	0.00594	0.00936	CcSEcCtD
Naphazoline—Keratitis—Doxorubicin—lung cancer	0.00548	0.00862	CcSEcCtD
Naphazoline—Asthenia—Crizotinib—lung cancer	0.00545	0.00857	CcSEcCtD
Naphazoline—Hyperhidrosis—Teniposide—lung cancer	0.00543	0.00855	CcSEcCtD
Naphazoline—NISCH—bronchus—lung cancer	0.00542	0.109	CbGeAlD
Naphazoline—Eye disorder—Erlotinib—lung cancer	0.00542	0.00853	CcSEcCtD
Naphazoline—Eye pain—Paclitaxel—lung cancer	0.0054	0.0085	CcSEcCtD
Naphazoline—Redness—Doxorubicin—lung cancer	0.00526	0.00829	CcSEcCtD
Naphazoline—Erythema—Erlotinib—lung cancer	0.00505	0.00795	CcSEcCtD
Naphazoline—Dizziness—Crizotinib—lung cancer	0.00502	0.0079	CcSEcCtD
Naphazoline—Asthenia—Pemetrexed—lung cancer	0.00498	0.00784	CcSEcCtD
Naphazoline—Asthenia—Gefitinib—lung cancer	0.00495	0.00779	CcSEcCtD
Naphazoline—NISCH—trachea—lung cancer	0.00487	0.0981	CbGeAlD
Naphazoline—Dizziness—Pemetrexed—lung cancer	0.00459	0.00722	CcSEcCtD
Naphazoline—Hyperglycaemia—Gemcitabine—lung cancer	0.00454	0.00715	CcSEcCtD
Naphazoline—Hypertension—Vinblastine—lung cancer	0.00454	0.00714	CcSEcCtD
Naphazoline—Nausea—Crizotinib—lung cancer	0.00451	0.0071	CcSEcCtD
Naphazoline—Discomfort—Vinblastine—lung cancer	0.00442	0.00696	CcSEcCtD
Naphazoline—Sweating—Irinotecan—lung cancer	0.00442	0.00695	CcSEcCtD
Naphazoline—Erythema—Vinorelbine—lung cancer	0.00437	0.00687	CcSEcCtD
Naphazoline—Sweating—Gemcitabine—lung cancer	0.0043	0.00677	CcSEcCtD
Naphazoline—Discomfort—Topotecan—lung cancer	0.00429	0.00676	CcSEcCtD
Naphazoline—Nausea—Pemetrexed—lung cancer	0.00412	0.00649	CcSEcCtD
Naphazoline—Nausea—Gefitinib—lung cancer	0.00409	0.00645	CcSEcCtD
Naphazoline—Asthenia—Teniposide—lung cancer	0.00403	0.00635	CcSEcCtD
Naphazoline—Hyperhidrosis—Topotecan—lung cancer	0.00403	0.00634	CcSEcCtD
Naphazoline—NISCH—bone marrow—lung cancer	0.00386	0.0778	CbGeAlD
Naphazoline—Lacrimation increased—Doxorubicin—lung cancer	0.00386	0.00607	CcSEcCtD
Naphazoline—Hyperglycaemia—Paclitaxel—lung cancer	0.0038	0.00598	CcSEcCtD
Naphazoline—Hypertension—Vinorelbine—lung cancer	0.00377	0.00593	CcSEcCtD
Naphazoline—Discomfort—Vinorelbine—lung cancer	0.00367	0.00578	CcSEcCtD
Naphazoline—Headache—Teniposide—lung cancer	0.00352	0.00554	CcSEcCtD
Naphazoline—Eye disorder—Cisplatin—lung cancer	0.00351	0.00552	CcSEcCtD
Naphazoline—Erythema—Gemcitabine—lung cancer	0.00351	0.00552	CcSEcCtD
Naphazoline—NISCH—lung—lung cancer	0.0035	0.0705	CbGeAlD
Naphazoline—Nausea—Teniposide—lung cancer	0.00334	0.00525	CcSEcCtD
Naphazoline—Erythema—Cisplatin—lung cancer	0.00327	0.00515	CcSEcCtD
Naphazoline—Eye disorder—Etoposide—lung cancer	0.00322	0.00506	CcSEcCtD
Naphazoline—Eye disorder—Paclitaxel—lung cancer	0.00315	0.00496	CcSEcCtD
Naphazoline—Hypertension—Irinotecan—lung cancer	0.00311	0.00489	CcSEcCtD
Naphazoline—Vision blurred—Cisplatin—lung cancer	0.00308	0.00485	CcSEcCtD
Naphazoline—Asthenia—Vinblastine—lung cancer	0.00308	0.00484	CcSEcCtD
Naphazoline—Discomfort—Irinotecan—lung cancer	0.00303	0.00477	CcSEcCtD
Naphazoline—Hypertension—Gemcitabine—lung cancer	0.00303	0.00477	CcSEcCtD
Naphazoline—Asthenia—Topotecan—lung cancer	0.00299	0.0047	CcSEcCtD
Naphazoline—Asthenia—Erlotinib—lung cancer	0.00296	0.00465	CcSEcCtD
Naphazoline—Discomfort—Gemcitabine—lung cancer	0.00295	0.00464	CcSEcCtD
Naphazoline—Erythema—Paclitaxel—lung cancer	0.00294	0.00462	CcSEcCtD
Naphazoline—Tension—Paclitaxel—lung cancer	0.00288	0.00454	CcSEcCtD
Naphazoline—Eye pain—Doxorubicin—lung cancer	0.00286	0.0045	CcSEcCtD
Naphazoline—Nervousness—Paclitaxel—lung cancer	0.00285	0.00449	CcSEcCtD
Naphazoline—Hyperhidrosis—Irinotecan—lung cancer	0.00284	0.00447	CcSEcCtD
Naphazoline—Dizziness—Vinblastine—lung cancer	0.00284	0.00446	CcSEcCtD
Naphazoline—Vision blurred—Paclitaxel—lung cancer	0.00277	0.00436	CcSEcCtD
Naphazoline—Hyperhidrosis—Gemcitabine—lung cancer	0.00277	0.00436	CcSEcCtD
Naphazoline—Dizziness—Topotecan—lung cancer	0.00275	0.00434	CcSEcCtD
Naphazoline—Discomfort—Cisplatin—lung cancer	0.00275	0.00433	CcSEcCtD
Naphazoline—Dizziness—Erlotinib—lung cancer	0.00273	0.00429	CcSEcCtD
Naphazoline—Headache—Vinblastine—lung cancer	0.00269	0.00423	CcSEcCtD
Naphazoline—Eye disorder—Docetaxel—lung cancer	0.00267	0.00421	CcSEcCtD
Naphazoline—ADRA1A—epithelium—lung cancer	0.00264	0.0532	CbGeAlD
Naphazoline—Somnolence—Irinotecan—lung cancer	0.00261	0.00411	CcSEcCtD
Naphazoline—Headache—Topotecan—lung cancer	0.00261	0.00411	CcSEcCtD
Naphazoline—Hypertension—Etoposide—lung cancer	0.00259	0.00407	CcSEcCtD
Naphazoline—Headache—Erlotinib—lung cancer	0.00258	0.00406	CcSEcCtD
Naphazoline—Hyperhidrosis—Cisplatin—lung cancer	0.00258	0.00406	CcSEcCtD
Naphazoline—Asthenia—Vinorelbine—lung cancer	0.00256	0.00402	CcSEcCtD
Naphazoline—Nausea—Vinblastine—lung cancer	0.00255	0.00401	CcSEcCtD
Naphazoline—Somnolence—Gemcitabine—lung cancer	0.00254	0.00401	CcSEcCtD
Naphazoline—Hypertension—Paclitaxel—lung cancer	0.00254	0.00399	CcSEcCtD
Naphazoline—Discomfort—Etoposide—lung cancer	0.00252	0.00397	CcSEcCtD
Naphazoline—Erythema—Docetaxel—lung cancer	0.00249	0.00392	CcSEcCtD
Naphazoline—ADRA2C—bronchus—lung cancer	0.00248	0.0499	CbGeAlD
Naphazoline—Nausea—Topotecan—lung cancer	0.00247	0.00389	CcSEcCtD
Naphazoline—Discomfort—Paclitaxel—lung cancer	0.00247	0.00389	CcSEcCtD
Naphazoline—Nausea—Erlotinib—lung cancer	0.00245	0.00385	CcSEcCtD
Naphazoline—NISCH—lymph node—lung cancer	0.00239	0.0482	CbGeAlD
Naphazoline—Hyperhidrosis—Etoposide—lung cancer	0.00236	0.00372	CcSEcCtD
Naphazoline—Dizziness—Vinorelbine—lung cancer	0.00236	0.00371	CcSEcCtD
Naphazoline—Hyperhidrosis—Paclitaxel—lung cancer	0.00232	0.00365	CcSEcCtD
Naphazoline—Drowsiness—Methotrexate—lung cancer	0.0023	0.00361	CcSEcCtD
Naphazoline—Headache—Vinorelbine—lung cancer	0.00223	0.00351	CcSEcCtD
Naphazoline—ADRA2C—trachea—lung cancer	0.00223	0.0448	CbGeAlD
Naphazoline—Sweating—Methotrexate—lung cancer	0.0022	0.00346	CcSEcCtD
Naphazoline—Somnolence—Etoposide—lung cancer	0.00217	0.00342	CcSEcCtD
Naphazoline—Hypertension—Docetaxel—lung cancer	0.00215	0.00338	CcSEcCtD
Naphazoline—Somnolence—Paclitaxel—lung cancer	0.00213	0.00335	CcSEcCtD
Naphazoline—Nausea—Vinorelbine—lung cancer	0.00212	0.00333	CcSEcCtD
Naphazoline—Asthenia—Irinotecan—lung cancer	0.00211	0.00332	CcSEcCtD
Naphazoline—ADRA2C—cardiac atrium—lung cancer	0.00209	0.0421	CbGeAlD
Naphazoline—Asthenia—Gemcitabine—lung cancer	0.00205	0.00323	CcSEcCtD
Naphazoline—Hyperglycaemia—Doxorubicin—lung cancer	0.00201	0.00317	CcSEcCtD
Naphazoline—Drowsiness—Doxorubicin—lung cancer	0.00199	0.00313	CcSEcCtD
Naphazoline—ADRA2A—bronchus—lung cancer	0.00198	0.0398	CbGeAlD
Naphazoline—Dizziness—Irinotecan—lung cancer	0.00194	0.00306	CcSEcCtD
Naphazoline—Eye disorder—Methotrexate—lung cancer	0.00193	0.00303	CcSEcCtD
Naphazoline—Asthenia—Cisplatin—lung cancer	0.00191	0.00301	CcSEcCtD
Naphazoline—Sweating—Doxorubicin—lung cancer	0.00191	0.003	CcSEcCtD
Naphazoline—Headache—Irinotecan—lung cancer	0.00184	0.0029	CcSEcCtD
Naphazoline—Somnolence—Docetaxel—lung cancer	0.00181	0.00284	CcSEcCtD
Naphazoline—Erythema—Methotrexate—lung cancer	0.00179	0.00282	CcSEcCtD
Naphazoline—Headache—Gemcitabine—lung cancer	0.00179	0.00282	CcSEcCtD
Naphazoline—ADRA2A—trachea—lung cancer	0.00178	0.0358	CbGeAlD
Naphazoline—Asthenia—Etoposide—lung cancer	0.00175	0.00276	CcSEcCtD
Naphazoline—Nausea—Irinotecan—lung cancer	0.00175	0.00275	CcSEcCtD
Naphazoline—Asthenia—Paclitaxel—lung cancer	0.00172	0.00271	CcSEcCtD
Naphazoline—Nausea—Gemcitabine—lung cancer	0.0017	0.00268	CcSEcCtD
Naphazoline—Vision blurred—Methotrexate—lung cancer	0.00169	0.00266	CcSEcCtD
Naphazoline—ADRA2A—cardiac atrium—lung cancer	0.00167	0.0336	CbGeAlD
Naphazoline—Eye disorder—Doxorubicin—lung cancer	0.00167	0.00263	CcSEcCtD
Naphazoline—Dizziness—Etoposide—lung cancer	0.00162	0.00254	CcSEcCtD
Naphazoline—ADRA2C—lung—lung cancer	0.0016	0.0322	CbGeAlD
Naphazoline—Dizziness—Paclitaxel—lung cancer	0.00158	0.00249	CcSEcCtD
Naphazoline—Nausea—Cisplatin—lung cancer	0.00158	0.00249	CcSEcCtD
Naphazoline—Erythema—Doxorubicin—lung cancer	0.00155	0.00245	CcSEcCtD
Naphazoline—Headache—Etoposide—lung cancer	0.00153	0.00241	CcSEcCtD
Naphazoline—Tension—Doxorubicin—lung cancer	0.00152	0.0024	CcSEcCtD
Naphazoline—Discomfort—Methotrexate—lung cancer	0.00151	0.00238	CcSEcCtD
Naphazoline—Nervousness—Doxorubicin—lung cancer	0.00151	0.00237	CcSEcCtD
Naphazoline—Headache—Paclitaxel—lung cancer	0.0015	0.00236	CcSEcCtD
Naphazoline—Vision blurred—Doxorubicin—lung cancer	0.00146	0.0023	CcSEcCtD
Naphazoline—Asthenia—Docetaxel—lung cancer	0.00146	0.00229	CcSEcCtD
Naphazoline—Nausea—Etoposide—lung cancer	0.00145	0.00229	CcSEcCtD
Naphazoline—Nausea—Paclitaxel—lung cancer	0.00142	0.00224	CcSEcCtD
Naphazoline—Hyperhidrosis—Methotrexate—lung cancer	0.00142	0.00223	CcSEcCtD
Naphazoline—Dizziness—Docetaxel—lung cancer	0.00134	0.00211	CcSEcCtD
Naphazoline—Hypertension—Doxorubicin—lung cancer	0.00134	0.00211	CcSEcCtD
Naphazoline—Discomfort—Doxorubicin—lung cancer	0.00131	0.00206	CcSEcCtD
Naphazoline—Somnolence—Methotrexate—lung cancer	0.0013	0.00205	CcSEcCtD
Naphazoline—ADRA2A—lung—lung cancer	0.00128	0.0257	CbGeAlD
Naphazoline—Headache—Docetaxel—lung cancer	0.00127	0.002	CcSEcCtD
Naphazoline—Hyperhidrosis—Doxorubicin—lung cancer	0.00123	0.00193	CcSEcCtD
Naphazoline—Nausea—Docetaxel—lung cancer	0.00121	0.0019	CcSEcCtD
Naphazoline—Somnolence—Doxorubicin—lung cancer	0.00113	0.00177	CcSEcCtD
Naphazoline—ADRA2C—lymph node—lung cancer	0.00109	0.022	CbGeAlD
Naphazoline—Asthenia—Methotrexate—lung cancer	0.00105	0.00165	CcSEcCtD
Naphazoline—Dizziness—Methotrexate—lung cancer	0.000968	0.00152	CcSEcCtD
Naphazoline—Headache—Methotrexate—lung cancer	0.000917	0.00144	CcSEcCtD
Naphazoline—Asthenia—Doxorubicin—lung cancer	0.00091	0.00143	CcSEcCtD
Naphazoline—ADRA2A—lymph node—lung cancer	0.000872	0.0176	CbGeAlD
Naphazoline—Nausea—Methotrexate—lung cancer	0.00087	0.00137	CcSEcCtD
Naphazoline—Dizziness—Doxorubicin—lung cancer	0.000838	0.00132	CcSEcCtD
Naphazoline—Headache—Doxorubicin—lung cancer	0.000794	0.00125	CcSEcCtD
Naphazoline—Nausea—Doxorubicin—lung cancer	0.000753	0.00119	CcSEcCtD
Naphazoline—ADRA2C—Signaling Pathways—TERT—lung cancer	6.87e-05	0.000265	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HES1—lung cancer	6.85e-05	0.000265	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOA1—lung cancer	6.79e-05	0.000262	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AVP—lung cancer	6.74e-05	0.00026	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KDR—lung cancer	6.73e-05	0.00026	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—RAF1—lung cancer	6.72e-05	0.00026	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CB—lung cancer	6.72e-05	0.000259	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FGFR1—lung cancer	6.67e-05	0.000258	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—IL2—lung cancer	6.64e-05	0.000256	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—POMC—lung cancer	6.59e-05	0.000254	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HIF1A—lung cancer	6.57e-05	0.000254	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CB—lung cancer	6.56e-05	0.000253	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—AKT1—lung cancer	6.52e-05	0.000252	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF1R—lung cancer	6.48e-05	0.00025	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—PIK3CA—lung cancer	6.48e-05	0.00025	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCL8—lung cancer	6.45e-05	0.000249	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CREBBP—lung cancer	6.42e-05	0.000248	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HES1—lung cancer	6.37e-05	0.000246	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOA1—lung cancer	6.34e-05	0.000245	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCL8—lung cancer	6.31e-05	0.000244	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KDR—lung cancer	6.28e-05	0.000243	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TP53—lung cancer	6.27e-05	0.000242	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ERBB3—lung cancer	6.27e-05	0.000242	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—RAF1—lung cancer	6.25e-05	0.000241	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KIT—lung cancer	6.2e-05	0.000239	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CG—lung cancer	6.2e-05	0.000239	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APC—lung cancer	6.2e-05	0.000239	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—NRAS—lung cancer	6.2e-05	0.000239	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—IL2—lung cancer	6.17e-05	0.000238	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOA1—lung cancer	6.16e-05	0.000238	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGF—lung cancer	6.13e-05	0.000236	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CB—lung cancer	6.1e-05	0.000235	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CD—lung cancer	6.09e-05	0.000235	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL2—lung cancer	6.03e-05	0.000233	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALB—lung cancer	6.01e-05	0.000232	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TERT—lung cancer	6.01e-05	0.000232	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—HRAS—lung cancer	5.99e-05	0.000231	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—MAPK3—lung cancer	5.94e-05	0.000229	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—POMC—lung cancer	5.9e-05	0.000228	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCL8—lung cancer	5.86e-05	0.000226	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FGFR1—lung cancer	5.83e-05	0.000225	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—BRAF—lung cancer	5.83e-05	0.000225	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ERBB3—lung cancer	5.82e-05	0.000225	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APC—lung cancer	5.79e-05	0.000223	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CG—lung cancer	5.79e-05	0.000223	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KIT—lung cancer	5.79e-05	0.000223	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—NRAS—lung cancer	5.79e-05	0.000223	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6R—lung cancer	5.75e-05	0.000222	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CREBBP—lung cancer	5.75e-05	0.000222	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HIF1A—lung cancer	5.74e-05	0.000222	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGF—lung cancer	5.72e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—EGFR—lung cancer	5.65e-05	0.000218	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CG—lung cancer	5.62e-05	0.000217	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL2—lung cancer	5.6e-05	0.000216	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TERT—lung cancer	5.58e-05	0.000215	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—MAPK3—lung cancer	5.54e-05	0.000214	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOA1—lung cancer	5.54e-05	0.000214	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—POMC—lung cancer	5.51e-05	0.000213	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KDR—lung cancer	5.49e-05	0.000212	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAP2K1—lung cancer	5.48e-05	0.000212	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CD—lung cancer	5.45e-05	0.00021	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—BRAF—lung cancer	5.44e-05	0.00021	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FGFR1—lung cancer	5.42e-05	0.000209	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—PIK3CA—lung cancer	5.4e-05	0.000208	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6R—lung cancer	5.38e-05	0.000208	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CREBBP—lung cancer	5.37e-05	0.000207	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—POMC—lung cancer	5.35e-05	0.000207	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HIF1A—lung cancer	5.34e-05	0.000206	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—KRAS—lung cancer	5.33e-05	0.000206	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CB—lung cancer	5.3e-05	0.000205	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—AKT1—lung cancer	5.29e-05	0.000204	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—EGFR—lung cancer	5.27e-05	0.000204	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—lung cancer	5.26e-05	0.000203	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CREBBP—lung cancer	5.21e-05	0.000201	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOA1—lung cancer	5.15e-05	0.000199	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAP2K1—lung cancer	5.12e-05	0.000198	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KDR—lung cancer	5.1e-05	0.000197	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CD—lung cancer	5.09e-05	0.000196	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KIT—lung cancer	5.06e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APC—lung cancer	5.06e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CG—lung cancer	5.06e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—NRAS—lung cancer	5.06e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PIK3CA—lung cancer	5.04e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGF—lung cancer	5e-05	0.000193	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—KRAS—lung cancer	4.98e-05	0.000192	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CD—lung cancer	4.94e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PIK3CA—lung cancer	4.9e-05	0.000189	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MDM2—lung cancer	4.88e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALB—lung cancer	4.88e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RAF1—lung cancer	4.86e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—MAPK3—lung cancer	4.85e-05	0.000187	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—POMC—lung cancer	4.82e-05	0.000186	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ERBB2—lung cancer	4.81e-05	0.000186	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—BRAF—lung cancer	4.76e-05	0.000184	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MTOR—lung cancer	4.75e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CB—lung cancer	4.75e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APC—lung cancer	4.7e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	4.7e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KIT—lung cancer	4.7e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—NRAS—lung cancer	4.7e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6R—lung cancer	4.7e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CREBBP—lung cancer	4.69e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGF—lung cancer	4.65e-05	0.000179	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—EGFR—lung cancer	4.61e-05	0.000178	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTEN—lung cancer	4.58e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PIK3CA—lung cancer	4.58e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL8—lung cancer	4.56e-05	0.000176	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MDM2—lung cancer	4.56e-05	0.000176	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RAF1—lung cancer	4.54e-05	0.000175	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HRAS—lung cancer	4.53e-05	0.000175	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	4.5e-05	0.000174	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ERBB2—lung cancer	4.49e-05	0.000174	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAP2K1—lung cancer	4.48e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—POMC—lung cancer	4.48e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CD—lung cancer	4.45e-05	0.000172	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MTOR—lung cancer	4.44e-05	0.000171	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CB—lung cancer	4.44e-05	0.000171	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—BRAF—lung cancer	4.42e-05	0.000171	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AKT1—lung cancer	4.41e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PIK3CA—lung cancer	4.41e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—EP300—lung cancer	4.37e-05	0.000169	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CASP3—lung cancer	4.37e-05	0.000169	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6R—lung cancer	4.37e-05	0.000169	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL2—lung cancer	4.36e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CREBBP—lung cancer	4.36e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—KRAS—lung cancer	4.36e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—lung cancer	4.34e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CB—lung cancer	4.31e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—EGFR—lung cancer	4.28e-05	0.000165	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—lung cancer	4.27e-05	0.000165	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL8—lung cancer	4.26e-05	0.000165	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCND1—lung cancer	4.25e-05	0.000164	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—JUN—lung cancer	4.24e-05	0.000164	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HRAS—lung cancer	4.24e-05	0.000163	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	4.16e-05	0.000161	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	4.13e-05	0.00016	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—lung cancer	4.13e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AKT1—lung cancer	4.12e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	4.11e-05	0.000159	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PTEN—lung cancer	4.1e-05	0.000158	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	4.09e-05	0.000158	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CASP3—lung cancer	4.08e-05	0.000157	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL2—lung cancer	4.07e-05	0.000157	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—lung cancer	4.05e-05	0.000156	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—KRAS—lung cancer	4.05e-05	0.000156	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AKT1—lung cancer	4e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	4e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MDM2—lung cancer	3.99e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RAF1—lung cancer	3.97e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCND1—lung cancer	3.97e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—JUN—lung cancer	3.96e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ERBB2—lung cancer	3.93e-05	0.000152	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EP300—lung cancer	3.91e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MTOR—lung cancer	3.88e-05	0.00015	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	3.88e-05	0.00015	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—lung cancer	3.86e-05	0.000149	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CDKN1A—lung cancer	3.84e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PTEN—lung cancer	3.83e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SRC—lung cancer	3.81e-05	0.000147	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AKT1—lung cancer	3.74e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL8—lung cancer	3.73e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTEN—lung cancer	3.72e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	3.72e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—lung cancer	3.71e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MDM2—lung cancer	3.7e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HRAS—lung cancer	3.7e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RAF1—lung cancer	3.69e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—STAT3—lung cancer	3.67e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NRAS—lung cancer	3.66e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EP300—lung cancer	3.66e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ERBB2—lung cancer	3.65e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MTOR—lung cancer	3.6e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	3.6e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	3.6e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CASP3—lung cancer	3.57e-05	0.000138	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL2—lung cancer	3.56e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SRC—lung cancer	3.55e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—EP300—lung cancer	3.55e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—lung cancer	3.54e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK3—lung cancer	3.51e-05	0.000135	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCND1—lung cancer	3.47e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—JUN—lung cancer	3.46e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL8—lung cancer	3.46e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—lung cancer	3.46e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HRAS—lung cancer	3.44e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—STAT3—lung cancer	3.43e-05	0.000132	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NRAS—lung cancer	3.42e-05	0.000132	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MYC—lung cancer	3.41e-05	0.000132	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—lung cancer	3.37e-05	0.00013	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	3.36e-05	0.00013	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTEN—lung cancer	3.35e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	3.34e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EGFR—lung cancer	3.34e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CASP3—lung cancer	3.31e-05	0.000128	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL2—lung cancer	3.31e-05	0.000128	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—lung cancer	3.29e-05	0.000127	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK3—lung cancer	3.28e-05	0.000126	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AKT1—lung cancer	3.27e-05	0.000126	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CA—lung cancer	3.23e-05	0.000125	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCND1—lung cancer	3.23e-05	0.000125	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—JUN—lung cancer	3.22e-05	0.000124	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EP300—lung cancer	3.2e-05	0.000123	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MYC—lung cancer	3.19e-05	0.000123	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KRAS—lung cancer	3.15e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—lung cancer	3.13e-05	0.000121	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	3.12e-05	0.00012	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EGFR—lung cancer	3.12e-05	0.00012	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTEN—lung cancer	3.11e-05	0.00012	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SRC—lung cancer	3.11e-05	0.00012	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AKT1—lung cancer	3.04e-05	0.000117	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—lung cancer	3.03e-05	0.000117	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—STAT3—lung cancer	3e-05	0.000116	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NRAS—lung cancer	2.99e-05	0.000115	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EP300—lung cancer	2.97e-05	0.000115	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KRAS—lung cancer	2.94e-05	0.000114	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	2.89e-05	0.000112	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SRC—lung cancer	2.89e-05	0.000111	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK3—lung cancer	2.86e-05	0.000111	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—lung cancer	2.81e-05	0.000109	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TP53—lung cancer	2.8e-05	0.000108	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MYC—lung cancer	2.78e-05	0.000107	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STAT3—lung cancer	2.78e-05	0.000107	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NRAS—lung cancer	2.78e-05	0.000107	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EGFR—lung cancer	2.72e-05	0.000105	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	2.7e-05	0.000104	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HRAS—lung cancer	2.68e-05	0.000103	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK3—lung cancer	2.66e-05	0.000103	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AKT1—lung cancer	2.64e-05	0.000102	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CA—lung cancer	2.63e-05	0.000101	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TP53—lung cancer	2.62e-05	0.000101	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MYC—lung cancer	2.59e-05	9.99e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KRAS—lung cancer	2.57e-05	9.93e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—lung cancer	2.56e-05	9.9e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EGFR—lung cancer	2.53e-05	9.77e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HRAS—lung cancer	2.5e-05	9.66e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—lung cancer	2.39e-05	9.24e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KRAS—lung cancer	2.39e-05	9.23e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT1—lung cancer	2.36e-05	9.13e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	2.36e-05	9.13e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TP53—lung cancer	2.29e-05	8.83e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT1—lung cancer	2.21e-05	8.53e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	2.2e-05	8.48e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HRAS—lung cancer	2.19e-05	8.44e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AKT1—lung cancer	2.15e-05	8.28e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TP53—lung cancer	2.12e-05	8.2e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—lung cancer	2.09e-05	8.08e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HRAS—lung cancer	2.03e-05	7.84e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—lung cancer	1.94e-05	7.51e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.93e-05	7.45e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.79e-05	6.93e-05	CbGpPWpGaD
